Role of Herpesvirus Complement-Binding Glycoprotein

Herold, Betsy C.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Physician Scientist Award (K11)
• Project #: 5K11AI000945-04
• Application #: 3085319
• Study Section: Microbiology and Infectious Diseases B Subcommittee (MID)
• Project Start: 1989-08-01
• Project End: 1992-08-31
• Budget Start: 1992-08-01
• Budget End: 1992-08-31
• Support Year: 4
• Fiscal Year: 1992

Institution

• Name: Northwestern University at Chicago
• Type: Schools of Dentistry
• DUNS #: 005436803
• City: Chicago
• State: IL
• Country: United States
• Zip Code: 60611

Publications

Herold, B C; Gerber, S I; Polonsky, T et al. (1995) Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology 206:1108-16

Herold, B C; Spear, P G (1994) Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry. Virology 203:166-71

Herold, B C; Visalli, R J; Susmarski, N et al. (1994) Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol 75 ( Pt 6):1211-22

Herold, B C; WuDunn, D; Soltys, N et al. (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 65:1090-8